In this issue
- Cardiovascular drug interactions with Paxlovid in COVID-19
- Myocarditis: Review article
- Myocarditis following COVID-19 mRNA vaccination of adolescents in Australia
- Cardiometabolic outcomes after COVID-19 infection
- Guidelines for ventricular arrhythmias and prevention of SCD
- Management of ACS in older adults
- NAFLD and risk of new-onset HF
- ATAGI guidance on myocarditis/pericarditis after COVID-19 vaccines
- TGA – new and extended registrations
- Associations between dietary fibre and CV risk factors
- Association of gestational diabetes with CV and cerebrovascular diseases
- COVID-19 resources
- Conferences, workshops and CPD
Download the Australian Cardiology Practice Review: Issue 23 here